Drug–drug interaction potential in men treated with enzalutamide: Mind the gap

AIMS: Metastatic castration‐resistant prostate cancer (mCRPC) patients are generally older patients with several co‐morbidities and are therefore at increased risk of complications due to drug–drug interactions (DDIs). We assessed the prevalence of potential DDIs in a cohort of mCRPC patients treate...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Clin Pharmacol
Päätekijät: Benoist, Guillemette Emma, van Oort, Inge M., Smeenk, Stella, Javad, Adrian, Somford, Diederik M., Burger, David M., Mehra, Niven, van Erp, Nielka P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2017
Aiheet:
Drug Interactions
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736854/
https://ncbi.nlm.nih.gov/pubmed/28881501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13425
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia